On Tuesday, shares of Welcure Drugs & Pharmaceuticals hit 5% upper circuit to ₹12.35 per share from its previous closing. The company completed export-sourcing assignments totalling ₹299.91 crore in Q1 FY22-23, earning a 5% commission. The company, acting as a procurement agent, fulfilled seven equal orders of ₹42.80 crore each for overseas clients like Gyandevi Export and Ravina International.